These data implicate CDH11 as a mediator of liver fibrosis, adding to the growing body of evidence that CDH11 is a common mediator of fibrosis in multiple tissues and suggest that targeting CDH11 is an intriguing therapeutic strategy for fibrotic disease including liver fibrosis. The gene discussed is CDH11; the disease is Hepatic fibrosis.